Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

282.92 -1.32 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises' ↗
The company is still in the early stages of adding patients with type 2 diabetes to its client base. 
Via Investor's Business Daily
News headline image
Insulet Corp. (NASDAQ:PODD) Delivers Strong Q2 2025 Earnings, Surpassing Revenue and EPS Forecasts ↗
Insulet Corp. (PODD) reported strong Q2 2025 earnings, beating revenue and EPS estimates with $649.1M in sales and $1.17 adjusted EPS. Stock rose 4.58% pre-market. Raised full-year guidance signals... 
Via Chartmill
News headline image
These S&P500 stocks are moving in today's pre-market session ↗
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday? 
Via Chartmill
News headline image
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Looking Into Insulet's Recent Short Interest ↗
 
Via Benzinga
News headline image
Insulet (PODD) Q2 Earnings: What To Expect
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
News headline image
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Senator Mullin Discloses Stock Trades 2.5 Years After They Were Made, Including One Up 134.5% ↗
 
Via Benzinga
News headline image
$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
1 Healthcare Stock on Our Buy List and 2 to Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
News headline image
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes ↗
An update on Sana Biotechnology. 
Via Benzinga
News headline image
2 High-Flying Stocks to Target This Week and 1 to Avoid
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
News headline image
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
From Insulet Corporation
Via Business Wire
News headline image
2 Mid-Cap Stocks Worth Your Attention and 1 to Brush Off
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Supply Chain
News headline image
3 Growth Stocks to Stash
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
Topics Artificial Intelligence
News headline image
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids ↗
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
News headline image
Tesla, Progress Software, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
These S&P500 stocks are moving in today's pre-market session ↗
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
INSULET CORP (NASDAQ:PODD) – A Strong Growth Stock with Technical Breakout Potential ↗
INSULET CORP (NASDAQ:PODD) shows strong revenue growth, high profitability, and a bullish technical setup, making it a noteworthy candidate for growth investors. 
Via Chartmill
News headline image
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
From Insulet Corporation
Via Business Wire
News headline image
Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Tuesday's session: gap up and gap down stock in the S&P500 index ↗
Stay updated with the S&P500 gap up and gap down stocks on Tuesday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
News headline image
Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.